Monte Rosa Therapeutics Inc — Financial Statistics (NASDAQ:GLUE) | MetaTrader

Open full chart

新闻

Monte Rosa股价因前列腺癌试验结果上涨

Monte Rosa shares rise on prostate cancer trial results

Monte Rosa公布前列腺癌药物积极试验数据

Monte Rosa reports positive trial data for prostate cancer drug

NeoGenomics (NEO) Q4 Earnings and Revenues Surpass Estimates

Piper Sandler将Monte Rosa股票目标价从27.50美元上调至37美元

Monte Rosa stock price target raised to $37 from $27.50 at Piper Sandler

Monte Rosa Therapeutics定价3亿美元公开发行

Monte Rosa Therapeutics prices $300 million public offering

GLUE Stock Up 45% on Positive Interim Data on Inflammation Drug

Monte Rosa Therapeutics (GLUE) is on the Move, Here's Why the Trend Could be Sustainable

Monte Rosa Therapeutics启动2亿美元公开发行